Why the study?
The study aimed to compare ivabradine versus bisoprolol in the short-term and long-term treatment of inappropriate sinus tachycardia.
Does ivabradine improve heart rate control and exercise capacity compared to bisoprolol in patients with inappropriate sinus tachycardia?
Does ivabradine improve heart rate control and exercise capacity compared to bisoprolol in patients with inappropriate sinus tachycardia?
Ivabradine is superior to bisoprolol for long-term heart rate control and exercise capacity improvement in patients with inappropriate sinus tachycardia, with better tolerability.
No takes yet. Share an insight, caveat, or question.
Ivabradine was associated with better tolerability and HR control than bisoprolol in IST; leaves open need for RCTs before practice change.
A 2021 study studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: